<code id='7E93B38B1C'></code><style id='7E93B38B1C'></style>
    • <acronym id='7E93B38B1C'></acronym>
      <center id='7E93B38B1C'><center id='7E93B38B1C'><tfoot id='7E93B38B1C'></tfoot></center><abbr id='7E93B38B1C'><dir id='7E93B38B1C'><tfoot id='7E93B38B1C'></tfoot><noframes id='7E93B38B1C'>

    • <optgroup id='7E93B38B1C'><strike id='7E93B38B1C'><sup id='7E93B38B1C'></sup></strike><code id='7E93B38B1C'></code></optgroup>
        1. <b id='7E93B38B1C'><label id='7E93B38B1C'><select id='7E93B38B1C'><dt id='7E93B38B1C'><span id='7E93B38B1C'></span></dt></select></label></b><u id='7E93B38B1C'></u>
          <i id='7E93B38B1C'><strike id='7E93B38B1C'><tt id='7E93B38B1C'><pre id='7E93B38B1C'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:focus    Page View:17
          om DiLenge (CQ in grey suit ) Flagship Pioneering Cambridge with US Congressman Raja Krishnamoorthi of Illinois were talking together at the event. Biotech companies demonstrating their medicines and materials at a "tech fair" designed to showcase the need to compete with Chinese biotech held at Harvard Kennedy School in Cambridge. The growing US backlash against the perceived national security threat posed by China's rising biotech industry
          Tom DiLenge of Flagship Pioneering (left) with U.S. Congressman Raja Krishnamoorthi of Illinois at a "tech fair" designed to showcase the need to compete with Chinese biotech held at Harvard Kennedy School in Cambridge, Mass. David L Ryan/The Boston Globe

          CAMBRIDGE, Mass. — The increasingly adversarial relationship between the United States and China has raised national security concerns about Chinese penetration into key sectors of the U.S. economy, such as technology, manufacturing, and clean energy.

          Now, some in Congress are raising alarms about China’s threat to another vital industry: biotechnology.

          advertisement

          A bipartisan group of lawmakers visited Massachusetts this week to call attention to that threat and call for strengthening U.S. life sciences companies, protecting their technologies, and safeguarding Americans’ genetic data from a Chinese biotech industry with close ties to the authoritarian state.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Medicare drug price negotiation hasn't dried up venture capital
          Medicare drug price negotiation hasn't dried up venture capital

          AdobeWASHINGTON—VenturecapitalistsarestillpouringmoneyintodrugresearchinspiteofMedicare’snewpowerton

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Grail spinoff by Illumina should end disastrous merger attempt

          AdobeIllumina,theleadingmakerofDNAsequencingmachines,saidSundaythatitwoulddivestGrail,thedeveloperof